Page last updated: 2024-11-02

perhexiline and Insulin Resistance

perhexiline has been researched along with Insulin Resistance in 3 studies

Perhexiline: 2-(2,2-Dicyclohexylethyl)piperidine. Coronary vasodilator used especially for angina of effort. It may cause neuropathy and hepatitis.

Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.

Research Excerpts

ExcerptRelevanceReference
"Nonalcoholic steatohepatitis (NASH) is defined histopathologically by the presence of macrovesicular steatosis, cellular ballooning, and inflammation."2.48A myriad of pathways to NASH. ( Larrain, S; Rinella, ME, 2012)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ceccarelli, SM1
Chomienne, O1
Gubler, M1
Arduini, A1
Larrain, S1
Rinella, ME1
Marazzi, G1
Volterrani, M1
Rosano, GM1

Reviews

1 review available for perhexiline and Insulin Resistance

ArticleYear
A myriad of pathways to NASH.
    Clinics in liver disease, 2012, Volume: 16, Issue:3

    Topics: Amiodarone; Anti-Retroviral Agents; Bacterial Infections; Cannabis; Diet; Fatty Liver; Genetic Disea

2012

Other Studies

2 other studies available for perhexiline and Insulin Resistance

ArticleYear
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
    Journal of medicinal chemistry, 2011, May-12, Volume: 54, Issue:9

    Topics: Animals; Carnitine; Carnitine O-Palmitoyltransferase; Catalytic Domain; Diabetes Mellitus, Type 2; E

2011
Metabolic agents in the management of diabetic coronary patients: a new era.
    International journal of cardiology, 2008, Jun-23, Volume: 127, Issue:1

    Topics: Acetanilides; Citric Acid Cycle; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies;

2008